Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 4/20 | 0.40 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA2 | P00918 | 4/20 | 0.40 |
| ▸ | CA9 | Q16790 | 4/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.36 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13759224 | 1.00 | TDP1 (0.43) | TDP1MEN1KMT2AGAACA12 | |
| SCHEMBL31395584 | 1.00 | TDP1 (0.43) | TDP1MEN1KMT2AGAACA12 | |
| SCHEMBL21071149 | 1.00 | TDP1 (0.43) | TDP1MEN1KMT2AGAACA12 | |
| SCHEMBL17739953 | 1.00 | TDP1 (0.43) | TDP1MEN1KMT2AGAACA12 | |
| SCHEMBL15432864 | 1.00 | TDP1 (0.43) | TDP1MEN1KMT2AGAACA12 | |
| SCHEMBL13612357 | 0.98 | TDP1 (0.44) | TDP1MEN1KMT2AGAACA12 | |
| SCHEMBL31290234 | 0.96 | TDP1 (0.40) | TDP1MEN1KMT2AGAACA12 | |
| SCHEMBL21070826 | 0.95 | CA12 (0.39) | TDP1MEN1KMT2AGAACA12 | |
| SCHEMBL20904591 | 0.92 | PLK1 (0.38) | TDP1MEN1KMT2AGAACA12 | |
| SCHEMBL29808480 | 0.92 | TDP1 (0.38) | TDP1MEN1KMT2AGAACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113480453-A | Synthesis method of NH2-PEG5-NHBoc | 苏州昊帆生物股份有限公司 | 2021-10-08 | — | — | CN | claimed |
| EP-4727537-A2 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | Adaxion Therapeutics, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20250064941-A1 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | ADAXION THERAPEUTICS, INC. | 2025-02-27 | — | — | US | disclosed |
| WO-2024259007-A2 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | OSPREY BIOPHARMACEUTICALS, INC. (US) | 2024-12-19 | — | — | WO | disclosed |
| CN-113480453-B | Synthesis method of NH2-PEG5-NHBoc | 苏州昊帆生物股份有限公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-113480453-A | Synthesis method of NH2-PEG5-NHBoc | 苏州昊帆生物股份有限公司 | 2021-10-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250064941-A1 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | SIGLEC7, SIGLEC9, CD2BP2 | TDP1 2616/4885MEN1 2796/4885KMT2A 2898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.